Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Emixustat Hydrochloride

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kubota Announces Post Hoc Analysis from Phase 3 Clinical Trial of Emixustat
    Kubota Announces Post Hoc Analysis from Phase 3 Clinical Trial of Emixustat

    03 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221003005323/en

    BUSINESSWIRE
    03 Oct 2022
    Share Share
    Kubota Vision Announced End of PIII Trial of Emixustat in Stargardt Disease
    Kubota Vision Announced End of PIII Trial of Emixustat in Stargardt Disease

    24 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220624005070/en

    BUSINESSWIRE
    24 Jun 2022
    Share Share
    Kubota Vision Announces Publication of Emixustat’s Pharmacodynamic Effects
    Kubota Vision Announces Publication of Emixustat’s Pharmacodynamic Effects

    24 Nov 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201124005350/en

    BUSINESSWIRE
    24 Nov 2020
    Share Share
    Kubota Vision Receives Orphan Products Clinical Trials Grants to Emixustat
    Kubota Vision Receives Orphan Products Clinical Trials Grants to Emixustat

    20 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200820005576/en

    BUSINESSWIRE
    20 Aug 2020
    Share Share
    Kubota Vision Completes Enrollment in the Emixustat Ph 3 Trial
    Kubota Vision Completes Enrollment in the Emixustat Ph 3 Trial

    01 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200501005154/en/Kubota-Vision-Completes-Enrollment-Emixustat-Phase-3

    BUSINESSWIRE
    01 May 2020
    Share Share
    Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride
    Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride

    07 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200106005230/en

    BUSINESS WIRE
    07 Jan 2020
    Share Share